Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity

Clinical Immunology

Volumn 92, Issue 1, 1999, Pages 90-96

  Xin, Ke Qin ^a,b   Lu, Yuan ^a   Hamajima, Kenji ^a   Fukushima, Jun ^a   Yang, Jun ^a   Inamura, Keiji ^a   Okuda, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RANTES;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033051038     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4730     Document Type: Article

References (28)

1. Donnelly J. J., Ulmer J. B., Shiver J. W., Liu M. A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
2. Okuda K., Xin K.-Q., Tsuji T., Asakura Y., Bukawa H., Tanaka S.-I., Koff W. C., Tani K., Okuda K., Honna K., Kawamoto S., Hamajima K., Fukushima J. DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunities. Vaccine. 15:1997;1049-1056.
3. Ishii N., Fukushima J., Kaneko T., Okada E., Tani K., Tanaka S.-I., Hamajima K., Xin K.-Q., Kawamoto S., Koff W., Nishioka K., Yasuda T., Okuda K. Cationic liposomes are a strong adjuvant for a human immunodeficiency virus type-1 (HIV-1) vaccine candidate constructed with HIV-1 env and rev genes. AIDS Res. Hum. Retrov. 13:1997;1421-1428.
4. Sasaki S., Hamajima K., Fukushima J., Ihata A., Ishii N., Horhi H., Okuda K. A comparison of intranasal and intramuscular DNA vaccination against human immunodeficiency virus type 1 with monophosphoryl lipid A adjuvant. Infect. Immun. 66:1998;823-826.
5. Sasaki S., Tsuji T., Hamajima K., Fukushima J., Ishii N., Kaneko T., Xin K.-Q., Mohri H., Aoki I., Okubo T., Nishioka K., Okuda K. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65:1997;3520-3528.
6. Sasaki S., Fukushima J., Hamajima K., Ishi N., Tsuji T., Xin K.-Q., Mohri H., Okuda K. Adjuvant effect of Ubenimex on a DNA vaccine for HIV-1. Clin. Exp. Immunol. 111:1998;30-35.
7. Sasaki S., Sumino K., Hamajima K., Fukushima J., Ishii N., Kawamoto S., Mohri H., Kensil C. R., Okuda K. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 adjuvant via intramuscular and intranasal routes. J. Virol. 72:1998;4931-4939.
8. Tsuji T., Hamajima K., Ishi N., Aoki I., Fukushima J., Xin K.-Q., Kawamoto S., Sasaki S., Matsunaga K.-I., Ishigatsubo Y., Tani K., Okubo T., Okuda K. Immunodulatory effects of plasmid expressing B7-2 on human immunodeficiency virus-1 specific cell-mediated immunity induced by plasmid-encoded the viral antigen. Eur. J. Immunol. 27:1997;782-787.
9. Xin K.-Q., Hamajima K., Sasaki S., Honsho H., Tsuji T., Ishii N., Cao X.-R., Lu Y., Fukushima J., Shapshak P., Kawamoto S., Okuda K. Intranasal administration of HIV-1 DNA vaccine with IL-2 expression plasmid enhances cell-mediated immunity against HIV-1. Immunology. 94:1998;438-444.
10. Tsuji T., Hamajima K., Fukushima J., Xin K.-Q., Ishii N., Aoki I., Ishigatsubo Y., Tani K., Kawamoto S., Nitta Y., Miyazaki J.-I., Koff W. C., Okubo T., Okuda K. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing interleukin-12. J. Immunol. 158:1997;4008-4013.
11. Xin K.-Q., Hamajima K., Sasaki S., Tsuji T., Watabe S., Okada E., Okuda K. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine. 17:1998;858-866.
12. Marco B., Clemens A. D. CC chemokines in allergic inflammation. Immunol. Today. 15:1994;127-133.
13. Devergne O., Marfaing-Koka A., Schall T. J., Leger-Ravet M. B., Sadick M., Peuchemaur M., Crevon M. C., Kim T., Galanaud P., Emilie D. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells. J. Exp. Med. 179:1994;1689-1694.
14. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. J. Immunol. 154:1995;1870-1878.
15. Okuda K., Bukawa H., Hamajima K., Kawamoto S., Sekigawa K., Yamada Y., Tanaka S., Ishii N., Aoki I., Nakamura M., Yamamoto H., Cullen B. R., Fukushima J. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV-1 env and rev gene products. AIDS Res. Hum. Retrov. 11:1995;933-943.
16. Niwa K., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-196.
17. Schall T. J., Simpson N. J., Mak J. Y. Molecular cloning and expression of the murine RANTES cytokine: structural and functional conservation between mouse and man. Eur. J. Immunol. 22:1992;1477-1481.
18. Clerici M., Lucey D., Zajac R., Boswell R., Gebel H., Takahashi H., Berzofsky J., Shearer G. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individual. J. Immunol. 146:1991;2214-2219.
19. Bukawa H., Sekigawa K., Hamajima K., Fukushima J., Yamada Y., Kiyono H., Okuda K. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat. Med. 1:1995;681-685.
20. Sasaki S., Fukushima J., Arai H., Kusakabe K., Hamajima K., Ishii N., Okuda K., Wahren B., Ruysschaert J.-M., Vandenbranden M., Kawamoto S., Okuda K. Human immunodeficiency virus type 1 specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol. 27:1997;3121-3129.
21. Tsuji T., Fukushima J., Hamajiam K., Ishii N., Aoki I., Bukawa H., Ishigatsubo Y., Tani K., Okubo T., Dort M. E., Okuda K. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid DNA vaccine. Immunology. 90:1997;1-6.
22. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J.-I., Wahren B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638-3647.
23. Salk J., Bretscher P. A., Salk P. L., Clerici M., Shearer G. M. A strategy for prophylactic vaccination against HIV. Science. 260:1993;1270-1272.
24. Clerici M., Shearer G. M. The Th1-Th2 hypotheses of HIV infection: New insights. Immunol. Today. 15:1994;575-581.
25. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T., Takiguchi M., Schultz T., McMichael A., Whittle H. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:1995;59-64.
26. Scott P. IL-12: Initiation cytokine for cell-mediated immunity. Science. 260:1993;496-497.
27. Grewal I. S., Rutledge B. J., Fiorillo J. A., Gu L., Gladue R. P., Flavell R. A., Rollins B. J. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: Abrogation by a second transgene expressing systemic MCP-1. J. Immunol. 159:1997;401-408.
28. Karpus W. J., Lukacs N. W., Kennedy K. J., Smith W. S., S. D. H., Barrett T. A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158:1997;4129-4136.